文献速递多重用药老年综合评估

减少65岁及以上成人抗胆碱能负荷的干预措施:系统综述

Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review.
PubMed 文献 · J Am Med Dir Assoc · 2019-07-24

本系统综述检索2010年1月至2019年2月文献,纳入8项研究(4项随机对照试验、4项前后对照研究),评估减少65岁及以上多重用药成人抗胆碱能负荷的干预。多数干预由药师实施个体化用药审查并反馈处方者;2项随机对照试验和全部非随机研究报告抗胆碱能负荷下降,无研究报告成本结局。

要点

  • 药师主导的用药审查与处方反馈是减少抗胆碱能负荷的主要干预形式。
  • 部分研究显示干预后抗胆碱能负荷下降,但证据质量与一致性有限。
  • 尚无研究报告成本效果,需在社区和高危人群中开展高质量试验。

核心结论

  • 药师可能适合实施减少抗胆碱能负荷的干预。
  • 这是首个针对老年人减少抗胆碱能负荷干预措施的系统综述。
  • 需要开发和测试高质量、实用的临床与成本效果试验,尤其在社区和抗胆碱能负荷危害高风险特定人群中。

研究设计与样本

  • 系统综述,检索CINAHL、Ovid MEDLINE、EMBASE和Cochrane CENTRAL数据库。
  • 纳入2010年1月至2019年2月发表的英文原始或二次研究,包括系统综述、随机对照试验、对照临床试验或非随机前后对照干预研究。
  • 共检索到5862条记录,最终纳入8项研究(4项随机对照试验、4项前后对照干预研究)。
  • 研究场景包括医院(4项)、社区(2项)、养老院(1项)和退休村(1项)。

主要发现

  • 多数研究(6/8)由药师单独或作为团队成员提供干预。
  • 大多数研究(7/8)涉及个体患者用药审查并向处方者反馈。
  • 4项随机对照试验中的2项和所有非随机研究报告干预后抗胆碱能负荷下降。
  • 无研究报告成本结局。

关键数值与推荐

  • 纳入对象为65岁及以上接受多重用药方案的成人。
  • 干预与常规照护比较,评估临床和成本效果。

临床怎么用

  • 药师可主导个体化用药审查并向处方者反馈,以降低老年多重用药患者的抗胆碱能负荷。
  • 目前证据不支持常规开展成本效果评估,临床实施时应关注高危人群并积累本地数据。

局限性

  • 纳入研究数量少(8项),设计异质性大(随机对照试验与前后对照研究混合)。
  • 无研究报告成本结局,无法评估经济性。
  • 检索截止2019年2月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Older age is associated with multimorbidity and polypharmacy with high anticholinergic burden (ACB). High ACB is linked to adverse events such as poor physical functioning, dementia, cardiovascular disease, and falls. Interventions are needed to reduce this burden. AIMS/OBJECTIVES: The aim was to systematically review the literature to identify and describe studies of clinical and cost-effectiveness of interventions designed to reduce ACB in adults (≥65 years) on polypharmacy regimes, compared with usual care. The objective was to answer the following questions: What are the contents of the interventions? Were these interventions clinically effective? Were these interventions cost effective?. DESIGN, SETTING, AND PARTICIPANTS: Systematic review of interventions to reduce anticholinergic burden in adults aged 65 and older in any clinical setting. METHODS: Eligible papers reported primary or secondary research describing any type of intervention including systematic reviews, randomized controlled trials (RCTs), controlled clinical trials, or nonrandomized pre-post intervention studies (PPIs) published in English from January 2010 to February 2019. Databases searched included CINAHL, Ovid MEDLINE, EMBASE, and The Cochrane Central Register of Controlled Trials (CENTRAL). RESULTS: The search yielded 5862 records. Eight studies (4 RCTs, 4 PPIs) conducted in hospital (4), community (2), nursing homes (1), and retirement villages (1) met the inclusion criteria. Pharmacists, either individually or as part of a team, provided the intervention in the majority of studies (6/8). Most (7/8) involved individual patient medication review followed by feedback to the prescriber. Two of the 4 RCTs and all non-RCTs reported a decrease in ACB following the intervention. No study reported cost outcome. CONCLUSIONS/IMPLICATIONS: Pharmacists may be well placed to implement an ACB reduction intervention. This is the first systematic review of interventions to reduce ACB in older adults, and it highlights the need for development and testing of high-quality pragmatic clinical and cost-effectiveness trials in community and specific patient populations at high risk of harm from ACB. [PROSPERO registration: CRD42018089764].

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Nakham A, Myint PK, Bond CM, et al. Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review. J Am Med Dir Assoc. 2019. PMID: 31351858. doi:10.1016/j.jamda.2019.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。